FIREBIRD

Medicinal value of the 'ZHAR-Ptitsa' variety

Mountain arnica is a demanding crop requiring precise agrotechnical practices. The 'ZHAR-Ptitsa' variety, developed by VILAR breeders, is the result of years of research aimed at adapting this valuable medicinal raw material to temperate climates. Unlike wild-growing forms, this variety provides predictable accumulation of biologically active substances, which is vital for the pharmaceutical industry.

Breeding features and key advantages

The work of the VILAR Institute has successfully standardized the cultivation process for arnica, a plant historically difficult to introduce into commercial farming. The efforts of originators L.G. Demenina and O.N. Gladysheva focus on enhancing disease resistance and ensuring stable inflorescence yields.

• Controlled biochemical profile: the concentration of flavonoids and sesquiterpene lactones meets rigorous industry standards.
• Scalability: the variety is adapted for mechanized cultivation and harvesting, which reduces production costs.
• Adaptability: successful breeding at the Srednevolzhskaya Zonal Experimental Station confirms the crop's ability to thrive in continental climatic zones.

Who is this for?

'ZHAR-Ptitsa' is primarily a professional solution for agricultural enterprises specializing in the cultivation of medicinal and aromatic plants. While home gardeners might value the plant for its aesthetics, commercial producers require certification and batch-to-batch quality consistency. This variety offers the reliability needed to plan supplies for cosmetic and pharmaceutical manufacturing. It is important to note, however, that arnica requires specific soil conditions—well-drained soil with moderate acidity is mandatory to unlock the full potential of the crop.